2 Top Canadian Stocks to Buy While They’re Still Cheap

Looking for some value on the TSX? Here are two bargain Canadian stocks that should be at the top of your watch list today.

| More on:

The market’s high price doesn’t mean Canadian investors can’t find any value on the TSX today. Even though the market is up 15% year to date, there are plenty of high-quality Canadian stocks trading at a discount.

The pandemic has created all kinds of volatility over the past year and a half. As a result, many market-leading companies have seen shares prices get slashed during this pandemic. 

In the short term, it’s been very difficult to predict market movements. But if you’re a long-term Foolish investor, the pandemic has presented lots of interesting buying opportunities.

I’ve reviewed two top Canadian stocks that are trading at a discount right now. Both have trailed the market year to date and are trading below all-time highs.

Still, they’ve still managed to crush the market’s returns over the past five years. And I’m betting they’ll continue to be market beaters for the next five, too. 

Canadian stock #1: Brookfield Renewable Partners

Renewable energy is one area of the market that I’m constantly recommending investors to have exposure to. Growth has been steadily rising for a few years now, but I think the best is yet to come for renewable energy stocks. 

For long-term investors, now’s a perfect time to be loading up on green energy stocks. The sector as a whole has been lagging the market’s returns this year. It’s only a matter of time, though, before the renewable energy leaders return to delivering market-beating growth. 

One of my top picks on the TSX is Brookfield Renewable Partners (TSX:BEP.UN)(NYSE:BEP). The $14 billion company is not only a leader in Canada but across the entire globe. It also offers its global customers a range of different renewable energy solutions.

The Canadian stock is down 10% year to date and close to 20% below all-time highs. Still, shareholders have enjoyed a gain of 140% over the past five years. 

If you’re looking for exposure to the growing renewable energy sector, you won’t find many better options than Brookfield Renewable Partners.

Canadian stock #2: Kinaxis

Kinaxis (TSX:KXS) is another Canadian stock that has struggled in 2021. The tech stock has trailed the market this year but it’s looking like it’s ready to return to all-time highs. Shares are up just 5% year to date, but the stock has been riding a 40% bull run since the beginning of June.

Kinaxis stock initially dropped during the COVID-19 market crash last year, but it didn’t take long to rebound. Demand for the tech company’s supply chain management software surged, as the pandemic created all kinds of changes in consumer purchase behaviour. 

Kinaxis’s software became that much more important, as businesses tried to keep up with the changes in consumer demand. The rise in demand for Kinaxis products and services led to the stock doubling in barely over three months last year.   

It’s been a volatile ride for Kinaxis shareholders over the past five years. Those that have been patient have been well rewarded, though. The Canadian stock is up a market-beating 215% since mid-2016.

When investing in a growth stock, volatility should be expected to a certain degree. Kinaxis stock trades at a price-to-sales ratio above 20. Its valuation is comparable to its tech peers, but it’s still an expensive stock compared to the broader market’s valuation. 

The trade-off with the high price is that Kinaxis shareholders have the possibility of earning market-beating growth. And if that’s what you’re looking for, I believe that Kinaxis is well worth the price that it’s trading at today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Nicholas Dobroruka owns shares of Brookfield Renewable Partners. The Motley Fool recommends KINAXIS INC.

More on Energy Stocks

engineer at wind farm
Energy Stocks

1 Canadian Utility Stock to Buy for Big Total Returns

Let's dive into why Fortis (TSX:FTS) remains a top utility stock long-term investors may want to consider right now.

Read more »

Canadian dollars in a magnifying glass
Energy Stocks

The Smartest Energy Stocks to Buy With $200 Right Now

The market is full of great growth and income stocks. Here's a look at two of the smartest energy stocks…

Read more »

Top TSX Stocks

A 6 Percent Dividend Yield Today! But Here’s Why I’m Buying This TSX Stock for the Long Term

Want a great stock to buy? You will regret not buying this TSX stock and its decades of growth and…

Read more »

ways to boost income
Energy Stocks

Act Fast: These 2 Canadian Energy Stocks Are Must-Buys Before Year-End

Here are two high-potential Canadian energy stocks with stable dividends you can consider adding to your portfolio before the year…

Read more »

canadian energy oil
Energy Stocks

2 No-Brainer Energy Stocks to Buy With $1,000 Right Now

If you have $1,000 to invest right now, CES Energy Solutions (TSX:CEU) and Enerflex (TSX:EFX) are no-brainer options.

Read more »

The letters AI glowing on a circuit board processor.
Energy Stocks

Maximizing Returns: How Canadian Investors Can Profit From AI’s Growing Energy Needs

Renewable energy stocks like Brookfield Renewable Partners (TSX:RNW) profit from AI's extreme energy usage.

Read more »

oil pump jack under night sky
Energy Stocks

3 No-Brainer Oil Stocks to Buy With $1,000 Right Now

The current geopolitical situation may not be conducive to oil price gains, but there are also positive catalysts.

Read more »

oil and natural gas
Energy Stocks

Best Stock to Buy Now: Suncor vs Cenovus?

Comparing Canada's energy giants: While Suncor stock dominated 2024, Cenovus could be a more compelling choice for 2025 with stronger…

Read more »